Myeloma Determination Study | Paul Richardson, MD | IMS 2022

Myeloma Determination Study | Paul Richardson, MD | IMS 2022
SARCLISA® (isatuximab) Update | Paul Richardson, MD | IMS 2022
REGN5458 Bispecific Antibody | Naresh Bumma, MD | IMS 2022
Fit Vs. Frail & Smoldering Myeloma | María-Victoria Mateos, MD, PhD | IMS 2022
(Guest Lecture): May 2022 - Translating Ideas Into Treatment - Dickran Kazandjian, MD
Translating Ideas Into Treatment - Dickran Kazandjian, MD | MCRT Miami, Florida May 21, 2022
Benjamin Derman, MD | MCRT Chicago, Illinois April 30, 2022
Translating Ideas Into Treatment - Dickran Kazandjian, MD | MCRT Miami, Florida May 21, 2022
Agne Paner, MD | MCRT Chicago, Illinois April 30, 2022